Vital Farms’ (VITL) executive chairperson Ohayer sells $12.6m in stock

Matthew Ohayer, Executive Chairperson and a director of Vital Farms, Inc. (NASDAQ:VITL), sold a total of 245,000 shares of common stock in a series of transactions on August 29 and September 2, 2025, for approximately $10,311,000. The sales come as Vital Farms, currently valued at $2.32 billion, has delivered an impressive 63% return over the past year and trades near its 52-week high of $53.12.

On August 29, Ohayer sold 100,000 shares at a weighted average price of $51.13, with individual sales prices ranging from $50.99 to $51.30. Following this, on September 2, Ohayer sold another 100,000 shares at a weighted average price of $51.98, with prices ranging from $51.57 to $52.55.

Additional sales on September 2, totaling 45,000 shares, were executed under a pre-arranged Rule 10b5-1 trading plan. These shares were sold in two tranches: 20,559 shares at a weighted average price of $51.52 (price range $50.99 - $51.98) and 24,441 shares at a weighted average price of $52.39 (price range $51.99 - $52.75), for a total of $2,339,663.

Following these transactions, Ohayer directly owns 6,582,070 shares of Vital Farms. Additionally, he has voting control over 716,000 shares held by his former spouse, in which he has no direct financial interest. For deeper insights into insider trading patterns and comprehensive financial analysis, including 16 additional ProTips, check out the detailed Pro Research Report available on InvestingPro.

In other recent news, Vital Farms has seen a series of positive developments. The company reported second-quarter results that exceeded expectations, prompting TD Cowen to raise its price target to $48 while maintaining a Buy rating. Management also increased its 2025 guidance above consensus estimates. DA Davidson highlighted Vital Farms’ strong financial performance, noting that the company "easily bested" its adjusted EBITDA expectations for the second quarter of 2025. This led DA Davidson to reiterate its Buy rating with a price target of $51.

Meanwhile, Mizuho raised its price target to $53, citing solid sales and EBITDA upside, as well as improvements in the supply chain. BMO Capital increased its price target to $60 following discussions with company leadership about growth potential in the U.S. pasture-raised egg market. DA Davidson also adjusted its price target to $52, pointing to alleviated inventory constraints and increased consumer awareness. These recent developments reflect a growing confidence among analysts in Vital Farms’ future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.